Mirum Pharmaceuticals, Inc. MIRM Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liabilities (current) of $2.35M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 43.1% year-over-year, from $1.64M to $2.35M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s operating lease liabilities (current) has grown at a 27.5% compound annual growth rate (CAGR), from $636K to $2.14M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.